Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alzamend Neuro, Inc

0.6794
+0.00941.40%
Post-market: 0.6701-0.0093-1.37%19:43 EDT
Volume:84.29K
Turnover:57.66K
Market Cap:4.48M
PE:-0.42
High:0.7035
Open:0.6900
Low:0.6701
Close:0.6700
Loading ...
Mar 27, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 04, 2025

Major Issues Report

Form 8-K - Current report
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Oct 03, 2024

Major Issues Report

Form 8-K - Current report
Sep 11, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2024

Major Issues Report

Form 8-K - Current report
Jul 30, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 12, 2024

Major Issues Report

Form 8-K - Current report
Jul 09, 2024

Major Issues Report

Form 8-K - Current report
Jul 08, 2024

Correspondence

Form CORRESP - Correspondence
Jul 03, 2024

Correspondence

Form CORRESP - Correspondence
Jul 03, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 26, 2024

Correspondence

Form CORRESP - Correspondence
Jun 26, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 03, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 22, 2024

Major Issues Report

Form 8-K - Current report